TESTBANKFOR c c
PATHOPHYSIOLOGY7TH
c c
c EDITIONBYJACQUELYNL. c c c
BANASIKCHAPTER1-54-
c c c
GRADESA+-2023-2024 c c
Chapter b01: bIntroduction bto
c c c
bPathophysiologybBanasik: bPathophysiology,
c c c
b7th bEdition
c c
MULTIPLEbCHOICE c
1. C.Q. bwas brecently bexposed bto bgroup bA bhemolytic bStreptococcus band bsubsequently
c c c c c c c c c c
c bdeveloped babpharyngeal binfection. bHis bclinic bexamination breveals ban boral btemperature bof
c c c c c c c c c c c
b102.3°F, bskin brash,bdysphagia, band breddened bthroat bmucosa bwith bmultiple bpustules. bHe
c c c c c c c c c c c c
c bcomplains bof bsore bthroat, bmalaise, band bjoint bstiffness. bA bthroat bculture bis bpositive bfor
c c c c c c c c c c c c c
c bStreptococcus, band bantibiotics bhavebbeen bprescribed. bThe betiology bof bC.Q.’s bdisease bis c c c c c c c c c c c
a. absorebthroat.
c c
b. streptococcalbinfection. c
c. geneticbsusceptibility. c
d. pharyngitis.
ANS: b B c
Etiology brefers bto bthe bproposed bcause bor bcauses bof ba bparticular bdisease bprocess. bA bsore
c c c c c c c c c c c c c c
bthroat bisbthe bmanifestation bof bthe bdisease bprocess. bGenetic bsusceptibility brefers bto binherited
c c c c c c c c c c c c c
btendency bto bdevelop ba bdisease. bPharyngitis brefers bto binflammation bof bthe bthroat band bis
c c c c c c c c c c c c c c
balso ba bclinical bmanifestation bof bthe bdisease bprocess.
c c c c c c c c
2. A b17-year-old bcollege-bound bstudent breceives ba bvaccine bagainst ban borganism bthat
c c c c c c c c c c
bcausesbmeningitis. bThis bis ban bexample bof
c c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
, ANS: b A c
Primarybprevention bis bprevention bofbdisease bbybalteringbsusceptibilitybor breducing bexposure
c c c c c c c c c c c
bforbsusceptible bindividuals, bin bthis bcase bby bproviding bvaccination. bSecondary bprevention bis
c c c c c c c c c c c c
bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease. bTertiary bprevention
c c c c c c c c c c c
bincludes brehabilitative band bsupportive bcare band battempts bto balleviate bdisability band brestore
c c c c c c c c c c c c
beffective bfunctioning. bDiseasebtreatment binvolves bmanagement bof bthe bdisease bonce bit bhas
c c c c c c c c c c c c
bdeveloped.
c
3. An bobese bbut botherwise bhealthy bteen bis bgiven ba bprescription bfor ba blow-calorie bdiet band
c c c c c c c c c c c c c c
c bexercisebprogram. bThis bis ban bexample bof
c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
ANS: b B c
Secondarybprevention bis bthe bearlybdetection, bscreening, band bmanagement bof bthebdisease
c c c c c c c c c c c
bsuch basbprescribing bdiet band bexercise bfor ban bindividual bwho bhas balready bdeveloped
c c c c c c c c c c c c c
bobesity. bPrimary bprevention bis bprevention bof bdisease bby baltering bsusceptibility bor
c c c c c c c c c c c
breducing bexposure bfor bsusceptible bindividuals. bTertiary bprevention bincludes brehabilitative
c c c c c c c c c
band bsupportive bcare band battempts bto balleviate bdisability band brestore beffective bfunctioning.
c c c c c c c c c c c c
bDisease btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
c c c c c c c c c c c
,4. A bpatient bwith bhigh bblood bpressure bwho bis botherwise bhealthy bis bcounseled bto brestrict
c c c c c c c c c c c c c
c bsodiumbintake. bThis bis ban bexample bof
c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
ANS: b B c
Secondary bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease,
c c c c c c c c c c c
bsuch bas bby bprescribing bsodium brestriction bfor bhigh bblood bpressure. bPrimary bprevention bis
c c c c c c c c c c c c c
bpreventionbof bdisease bby baltering bsusceptibility bor breducing bexposure bfor bsusceptible
c c c c c c c c c c c
bindividuals. bTertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts
c c c c c c c c c c
bto balleviate bdisability band brestore beffective bfunctioning. bDisease btreatment binvolves
c c c c c c c c c c
bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
c c c c c c c c
5. After bsuffering ba bheart battack, ba bmiddle-aged bman bis bcounseled bto btake ba bcholesterol-
c c c c c c c c c c c c c
loweringbmedication. bThis bis ban bexample bof c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
ANS: b C c
Tertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts bto balleviate
c c c c c c c c c c
bdisability band brestore beffective bfunctioning bsuch bas bprescribing ba bcholesterol-lowering
c c c c c c c c c c
bmedication bfollowing ba bheart battack. bPrimary bprevention bis bprevention bof bdisease bby
c c c c c c c c c c c c
balteringbsusceptibility bor breducing bexposure bfor bsusceptible bindividuals. bSecondary
c c c c c c c c c
bprevention bis bthebearly bdetection, bscreening, band bmanagement bof bthe bdisease. bDisease
c c c c c c c c c c c c
btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
c c c c c c c c c c
6. A bpatient bhas bbeen bexposed bto bmeningococcal bmeningitis, bbut bis bnot byet bdemonstrating
c c c c c c c c c c c c
bsigns bofbthis bdisease. bThis bstagebof billness bis bcalled bthestage.
c c c c c c c c c c c
a. prodromal
b. latent
c. sequela
d. convalescence
ANS: b B c
Incubation brefers bto bthe binterval bbetween bexposure bof babtissue bto banbinjurious bagent band bthe
c c c c c c c c c c c c c c c
bfirstbappearance bof bsigns band bsymptoms. bIn binfectious bdiseases, bthis bperiod bis boften bcalled
c c c c c c c c c c c c c c
bthe bincubation b(latent) bperiod. bProdromal brefers bto bthe bappearance bof bthe bfirst bsigns band
c c c c c c c c c c c c c c
bsymptoms bindicating bthe bonset bof ba bdisease. bThese bare boften bnonspecific, bsuch bas
c c c c c c c c c c c c c
bheadache, bmalaise, banorexia, band bnausea, bwhich bare bassociated bwith ba bnumber bof
c c c c c c c c c c c c
bdifferent bdiseases. bSequela brefersbto bsubsequent bpathologic bcondition bresulting bfrom ba
c c c c c c c c c c c
bdisease. bConvalescence bis bthe bstage bof brecoverybafter ba bdisease, binjury, bor bsurgical
c c c c c c c c c c c c c
boperation.
c
7. Abdisease bthat bis bnativebto babparticular bregion bis bcalled
c c c c c c c c c c
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.
, ANS: b B c
A bdisease bthat bis bnative bto ba bparticular bregion bis bcalled bendemic. bAn bepidemic bis ba
c c c c c c c c c c c c c c c
bdisease bthatbspreads bto bmany bindividuals bat bthe bsame btime. bPandemics bare bepidemics bthat
c c c c c c c c c c c c c c
baffect blarge bgeographic bregions, bperhaps bspreading bworldwide. bEthnographic bdoes bnot
c c c c c c c c c c
bdescribe ba bdisease bdistribution bpattern.
c c c c c
8. In bgeneral, bwithbaging, borganbsizeband bfunction
c c c c c c c
a. increase.
b. decrease.
c. remainbthe bsame. c c
d. arebunknown. c
ANS: b B c
In bgeneral, bwithbaging, borganbsizeband bfunctionbdecrease.
c c c c c c c c
9. Thebstagebduringbwhich bthebpatient bfunctions bnormally, balthough bthe bdiseasebprocesses bare
c c c c c c c c c c c c
cbwellbestablished, bis breferred bto bas
c c c c c
a. latent.
b. subclinical.
c. prodromal.
d. convalescence.
ANS: b B c
Thebstagebduringbwhich bthebpatient bfunctions bnormally, balthough bthebdiseasebprocesses bare
c c c c c c c c c c c c
bwellbestablished, bis bcalled bthe bsubclinical bstage. bThe binterval bbetween bexposure bof ba btissue
c c c c c c c c c c c c c c
bto ban binjurious bagent band bthe bfirst bappearance bof bsigns band bsymptoms bmay bbe bcalled ba
c c c c c c c c c c c c c c c c
blatent bperiod bor, bin bthe bcase bof binfectious bdiseases, ban bincubation bperiod. bThe bprodromal
c c c c c c c c c c c c c c
bperiod, bor bprodrome, brefers bto bthe bappearance bof bthe bfirst bsigns band bsymptoms bindicating
c c c c c c c c c c c c c c
bthe bonset bof ba bdisease. bConvalescence bis bthebstagebof brecoverybafterbabdisease, binjury, bor
c c c c c c c c c c c c c c c c
bsurgical boperation.
c c
MULTIPLEbRESPONSE c
1. Your bpatient’s bred bblood bcell bcount bis bslightly belevated btoday.bThis bmight bbe
c c c c c c c c c c c c
cbexplained bbyb(Select ball bthat bapply.) c c c c c
a. genderbdifference. c
b. situationalbfactors. c
c. normalbvariation. c
d. culturalbvariation. c
e. illness.
ANS: b A, bB, bC, bE c c c c
Gender,bsituations b(e.g., baltitude), bnormal bvariations, bandbillness bmayball bdeterminebred
c c c c c c c c c c c
bbloodbcell bcount. bCulturebaffects bhowbmanifestations bare bperceived b(normal bversus
c c c c c c c c c c c
babnormal).
c
2. Socioeconomicbfactors binfluence bdiseasebdevelopment bbecause bof b(Select ball bthat bapply.) c c c c c c c c c c
a. genetics.
b. environmental btoxins. c
c. overcrowding.
d. nutrition.
e. hygiene.
PATHOPHYSIOLOGY7TH
c c
c EDITIONBYJACQUELYNL. c c c
BANASIKCHAPTER1-54-
c c c
GRADESA+-2023-2024 c c
Chapter b01: bIntroduction bto
c c c
bPathophysiologybBanasik: bPathophysiology,
c c c
b7th bEdition
c c
MULTIPLEbCHOICE c
1. C.Q. bwas brecently bexposed bto bgroup bA bhemolytic bStreptococcus band bsubsequently
c c c c c c c c c c
c bdeveloped babpharyngeal binfection. bHis bclinic bexamination breveals ban boral btemperature bof
c c c c c c c c c c c
b102.3°F, bskin brash,bdysphagia, band breddened bthroat bmucosa bwith bmultiple bpustules. bHe
c c c c c c c c c c c c
c bcomplains bof bsore bthroat, bmalaise, band bjoint bstiffness. bA bthroat bculture bis bpositive bfor
c c c c c c c c c c c c c
c bStreptococcus, band bantibiotics bhavebbeen bprescribed. bThe betiology bof bC.Q.’s bdisease bis c c c c c c c c c c c
a. absorebthroat.
c c
b. streptococcalbinfection. c
c. geneticbsusceptibility. c
d. pharyngitis.
ANS: b B c
Etiology brefers bto bthe bproposed bcause bor bcauses bof ba bparticular bdisease bprocess. bA bsore
c c c c c c c c c c c c c c
bthroat bisbthe bmanifestation bof bthe bdisease bprocess. bGenetic bsusceptibility brefers bto binherited
c c c c c c c c c c c c c
btendency bto bdevelop ba bdisease. bPharyngitis brefers bto binflammation bof bthe bthroat band bis
c c c c c c c c c c c c c c
balso ba bclinical bmanifestation bof bthe bdisease bprocess.
c c c c c c c c
2. A b17-year-old bcollege-bound bstudent breceives ba bvaccine bagainst ban borganism bthat
c c c c c c c c c c
bcausesbmeningitis. bThis bis ban bexample bof
c c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
, ANS: b A c
Primarybprevention bis bprevention bofbdisease bbybalteringbsusceptibilitybor breducing bexposure
c c c c c c c c c c c
bforbsusceptible bindividuals, bin bthis bcase bby bproviding bvaccination. bSecondary bprevention bis
c c c c c c c c c c c c
bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease. bTertiary bprevention
c c c c c c c c c c c
bincludes brehabilitative band bsupportive bcare band battempts bto balleviate bdisability band brestore
c c c c c c c c c c c c
beffective bfunctioning. bDiseasebtreatment binvolves bmanagement bof bthe bdisease bonce bit bhas
c c c c c c c c c c c c
bdeveloped.
c
3. An bobese bbut botherwise bhealthy bteen bis bgiven ba bprescription bfor ba blow-calorie bdiet band
c c c c c c c c c c c c c c
c bexercisebprogram. bThis bis ban bexample bof
c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
ANS: b B c
Secondarybprevention bis bthe bearlybdetection, bscreening, band bmanagement bof bthebdisease
c c c c c c c c c c c
bsuch basbprescribing bdiet band bexercise bfor ban bindividual bwho bhas balready bdeveloped
c c c c c c c c c c c c c
bobesity. bPrimary bprevention bis bprevention bof bdisease bby baltering bsusceptibility bor
c c c c c c c c c c c
breducing bexposure bfor bsusceptible bindividuals. bTertiary bprevention bincludes brehabilitative
c c c c c c c c c
band bsupportive bcare band battempts bto balleviate bdisability band brestore beffective bfunctioning.
c c c c c c c c c c c c
bDisease btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
c c c c c c c c c c c
,4. A bpatient bwith bhigh bblood bpressure bwho bis botherwise bhealthy bis bcounseled bto brestrict
c c c c c c c c c c c c c
c bsodiumbintake. bThis bis ban bexample bof
c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
ANS: b B c
Secondary bprevention bis bthe bearly bdetection, bscreening, band bmanagement bof bthe bdisease,
c c c c c c c c c c c
bsuch bas bby bprescribing bsodium brestriction bfor bhigh bblood bpressure. bPrimary bprevention bis
c c c c c c c c c c c c c
bpreventionbof bdisease bby baltering bsusceptibility bor breducing bexposure bfor bsusceptible
c c c c c c c c c c c
bindividuals. bTertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts
c c c c c c c c c c
bto balleviate bdisability band brestore beffective bfunctioning. bDisease btreatment binvolves
c c c c c c c c c c
bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
c c c c c c c c
5. After bsuffering ba bheart battack, ba bmiddle-aged bman bis bcounseled bto btake ba bcholesterol-
c c c c c c c c c c c c c
loweringbmedication. bThis bis ban bexample bof c c c c c c
a. primarybprevention. c
b. secondarybprevention. c
c. tertiarybprevention. c
d. diseasebtreatment. c
ANS: b C c
Tertiary bprevention bincludes brehabilitative band bsupportive bcare band battempts bto balleviate
c c c c c c c c c c
bdisability band brestore beffective bfunctioning bsuch bas bprescribing ba bcholesterol-lowering
c c c c c c c c c c
bmedication bfollowing ba bheart battack. bPrimary bprevention bis bprevention bof bdisease bby
c c c c c c c c c c c c
balteringbsusceptibility bor breducing bexposure bfor bsusceptible bindividuals. bSecondary
c c c c c c c c c
bprevention bis bthebearly bdetection, bscreening, band bmanagement bof bthe bdisease. bDisease
c c c c c c c c c c c c
btreatment binvolves bmanagement bof bthe bdisease bonce bit bhas bdeveloped.
c c c c c c c c c c
6. A bpatient bhas bbeen bexposed bto bmeningococcal bmeningitis, bbut bis bnot byet bdemonstrating
c c c c c c c c c c c c
bsigns bofbthis bdisease. bThis bstagebof billness bis bcalled bthestage.
c c c c c c c c c c c
a. prodromal
b. latent
c. sequela
d. convalescence
ANS: b B c
Incubation brefers bto bthe binterval bbetween bexposure bof babtissue bto banbinjurious bagent band bthe
c c c c c c c c c c c c c c c
bfirstbappearance bof bsigns band bsymptoms. bIn binfectious bdiseases, bthis bperiod bis boften bcalled
c c c c c c c c c c c c c c
bthe bincubation b(latent) bperiod. bProdromal brefers bto bthe bappearance bof bthe bfirst bsigns band
c c c c c c c c c c c c c c
bsymptoms bindicating bthe bonset bof ba bdisease. bThese bare boften bnonspecific, bsuch bas
c c c c c c c c c c c c c
bheadache, bmalaise, banorexia, band bnausea, bwhich bare bassociated bwith ba bnumber bof
c c c c c c c c c c c c
bdifferent bdiseases. bSequela brefersbto bsubsequent bpathologic bcondition bresulting bfrom ba
c c c c c c c c c c c
bdisease. bConvalescence bis bthe bstage bof brecoverybafter ba bdisease, binjury, bor bsurgical
c c c c c c c c c c c c c
boperation.
c
7. Abdisease bthat bis bnativebto babparticular bregion bis bcalled
c c c c c c c c c c
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.
, ANS: b B c
A bdisease bthat bis bnative bto ba bparticular bregion bis bcalled bendemic. bAn bepidemic bis ba
c c c c c c c c c c c c c c c
bdisease bthatbspreads bto bmany bindividuals bat bthe bsame btime. bPandemics bare bepidemics bthat
c c c c c c c c c c c c c c
baffect blarge bgeographic bregions, bperhaps bspreading bworldwide. bEthnographic bdoes bnot
c c c c c c c c c c
bdescribe ba bdisease bdistribution bpattern.
c c c c c
8. In bgeneral, bwithbaging, borganbsizeband bfunction
c c c c c c c
a. increase.
b. decrease.
c. remainbthe bsame. c c
d. arebunknown. c
ANS: b B c
In bgeneral, bwithbaging, borganbsizeband bfunctionbdecrease.
c c c c c c c c
9. Thebstagebduringbwhich bthebpatient bfunctions bnormally, balthough bthe bdiseasebprocesses bare
c c c c c c c c c c c c
cbwellbestablished, bis breferred bto bas
c c c c c
a. latent.
b. subclinical.
c. prodromal.
d. convalescence.
ANS: b B c
Thebstagebduringbwhich bthebpatient bfunctions bnormally, balthough bthebdiseasebprocesses bare
c c c c c c c c c c c c
bwellbestablished, bis bcalled bthe bsubclinical bstage. bThe binterval bbetween bexposure bof ba btissue
c c c c c c c c c c c c c c
bto ban binjurious bagent band bthe bfirst bappearance bof bsigns band bsymptoms bmay bbe bcalled ba
c c c c c c c c c c c c c c c c
blatent bperiod bor, bin bthe bcase bof binfectious bdiseases, ban bincubation bperiod. bThe bprodromal
c c c c c c c c c c c c c c
bperiod, bor bprodrome, brefers bto bthe bappearance bof bthe bfirst bsigns band bsymptoms bindicating
c c c c c c c c c c c c c c
bthe bonset bof ba bdisease. bConvalescence bis bthebstagebof brecoverybafterbabdisease, binjury, bor
c c c c c c c c c c c c c c c c
bsurgical boperation.
c c
MULTIPLEbRESPONSE c
1. Your bpatient’s bred bblood bcell bcount bis bslightly belevated btoday.bThis bmight bbe
c c c c c c c c c c c c
cbexplained bbyb(Select ball bthat bapply.) c c c c c
a. genderbdifference. c
b. situationalbfactors. c
c. normalbvariation. c
d. culturalbvariation. c
e. illness.
ANS: b A, bB, bC, bE c c c c
Gender,bsituations b(e.g., baltitude), bnormal bvariations, bandbillness bmayball bdeterminebred
c c c c c c c c c c c
bbloodbcell bcount. bCulturebaffects bhowbmanifestations bare bperceived b(normal bversus
c c c c c c c c c c c
babnormal).
c
2. Socioeconomicbfactors binfluence bdiseasebdevelopment bbecause bof b(Select ball bthat bapply.) c c c c c c c c c c
a. genetics.
b. environmental btoxins. c
c. overcrowding.
d. nutrition.
e. hygiene.
